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a b s t r a c t
Oxidative stress and the ubiquitineproteasome system play a key role in the pathogenesis of Parkinson
disease. Although the herbicide paraquat is an environmental factor that is involved in the etiology of
Parkinson disease, the role of 26S proteasome in paraquat toxicity remains to be determined. Using PC12
cells overexpressing a ﬂuorescent protein fused to the proteasome degradation signal, we report here
that paraquat yielded an inhibitory effect on 26S proteasome activity without an obvious decline in 20S
proteasome activity. Relative low concentrations of proteasome inhibitors caused the accumulation of
nuclear factor erythroid 2-related factor 2 (Nrf2), which is targeted to the ubiquitineproteasome system,
and activated the antioxidant response element (ARE)-dependent transcription. Paraquat also upregu-
lated the protein level of Nrf2 without increased expression of Nrf2 mRNA, and activated the Nrf2eARE
pathway. Consequently, paraquat induced expression of Nrf2-dependent ARE-driven genes, such as g-
glutamylcysteine synthetase, catalase, and hemeoxygenase-1. Knockdown of Nrf2 or inhibition of g-
glutamylcysteine synthetase and catalase exacerbated paraquat-induced toxicity, whereas suppression of
hemeoxygenase-1 did not. These data indicate that the compensatory activation of the Nrf2eARE
pathway via inhibition of 26S proteasome serves as part of a cellular defense mechanism to protect
against paraquat toxicity.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
1. Introduction
Parkinson disease (PD) is a common neurodegenerative disorder
that is characterized by a relatively selective loss of dopaminergic
neurons and by the appearance of Lewy bodies in the substantia
nigra. Although the cause of neuronal loss remains unknown,
oxidative stress and the ubiquitineproteasome system (UPS) are
thought to play important roles in this process (1, 2). In the
midbrain of patients with PD, the activities of peroxidase and
catalase are reduced, and the amount of glutathione is decreased (3,
4). These observations indicate that antioxidant defense systems
collapse in the dopaminergic neurons of patients with PD. The
expression of antioxidant enzymes is primarily controlled by the
nuclear factor erythroid 2-related factor 2 (Nrf2)eantioxidant
response element (ARE) pathway. In response to oxidative stress,
Nrf2 is translocated to the nucleus and binds to ARE, resulting in the
transcriptional activation of phase 2 detoxifying and antioxidant
enzymes (5). Ramsey et al. (6) reported the nuclear localization of
Nrf2 in the remaining dopaminergic neurons of patients with PD.
Some forms of familial PD are caused by mutations in compo-
nents related to UPS, which highlights the potential importance of
UPS in PD (7, 8). Importantly, in the substantia nigra of patients
with sporadic PD, proteasomal function is reduced by 30%e40%,
and the levels of the a-subunit of the proteasome and PA700 pro-
teasome activator are reduced (9, 10). Severe impairment of UPS
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reportedly causes an increase in ubiquitin- and a-synuclein-posi-
tive aggregation, along with dopaminergic neuronal death (11, 12).
However, UPS is responsible for the degradation of short-lived
proteins as well as misfolded proteins. For example, the tran-
scription factor Nrf2 is degraded by UPS under normal conditions
(13); therefore, proteasomal inhibition induces the accumulation of
Nrf2, the translocation of Nrf2 into nuclei, and the activation of
ARE-driven transcription of antioxidant genes (14, 15). Previous
studies demonstrated that mild inhibition of proteasome activity
affords protection against toxin-induced cell death, at least in part,
via the activation of the Nrf2eARE pathway (15e18). Because
proteasomal inhibition activates both neuroprotective and pro-
apoptotic response pathways (19), the role of UPS impairment in
the cell-death process remains controversial.
Human epidemiological studies indicate an association between
exposure to pesticides and an increased risk for PD (20). Some
pesticides excert inhibitory effects on 26S proteasome activity
without affecting 20S proteasome activity (21). Evidence from
epidemiological and experimental studies (22, 23) strongly suggest
the existence of link between paraquat, a widely used herbicide,
and sporadic PD. However, the effect of paraquat on 26S protea-
some activity remains to be determined because of the lack of
cellular uptake in the previous study (21). Our previous report has
demonstrated that paraquat was incorporated into PC12 cells via
the dopamine transporter (24). Furthermore, exposure of PC12 cells
to paraquat (50 mM) caused delayed toxicity from 36 h onward
through endogenous dopamine-mediated oxidative stress. There-
fore, we used the concentration of paraquat as an experimental
model of dopaminergic neuronal death in PD. In the present study,
we used PC12 cells overexpressing a green ﬂuorescent protein that
fused to the proteasome degradation signal to examine the effect of
paraquat on 26S proteasome activity and the role of 26S protea-
some activity in paraquat-induced toxicity.
2. Materials and methods
2.1. Materials
Paraquat dichloride and bilirubin were purchased from Nacalai
Tesque (Kyoto, Japan). Benzyloxycarbonyl-Leu-Leu-leucinal
(MG132), lactacystin, and 3-amino-1,2,4-triazole were obtained
from Calbiochem (San Diego, CA, USA). a-Methyl-DL-p-tyrosine
methyl ester hydrochloride, ascorbic acid, and L-buthionine-[S,R]-
sulfoximine (BSO) were purchased from SigmaeAldrich Co. (St.
Louis, MO, USA). Nerve growth factor (NGF) was from Promega Co.
(Madison, WI, USA).
2.2. Cell culture
Rat adrenal pheochromocytoma PC12 cells were maintained as
described previously (24). NGF-induced differentiation was con-
ducted as described previously (25).
2.3. Evaluation of cell viability
Cell viability was determined using the lactate dehydrogenase
(LDH) release assay. Brieﬂy, 10 mL of culture supernatant was mixed
with 90 mL of the LDH substrate mixture (174 mM lactate, 1.5 mM
nicotinamide adenine dinucleotide, 815 mM nitroblue tetrazolium,
and 13.3 U/mL diaphorase (Oriental Yeast Co., Tokyo, Japan) in
50 mM Tris-HCl; pH 8.5). After incubation for 20 min at room
temperature, absorbance was measured at 570 nm. Cell viability
was calculated as 100% minus the ratio of the activity of the
released LDH to total activity; LDH was released by exposure to
paraquat (300 mM) for 48 h.
2.4. Determination of cellular ubiquitin-dependent 26S proteasome
activity
PC12 cells were transfected with the Proteasome Sensor Vector
(pZsProSensor-1, Takara Bio, Shiga, Japan) using Lipofectamine
2000 (Life technologies, Carlsbad, CA, USA) according to the man-
ufacturer's instructions. Stably transfected cell lines were generated
via selectionwith G418 (400 mg/mL). Treated cells were trypsinized
for 5 min and suspended as individual cells before the ﬂow cyto-
metric analysis. Cellular ﬂuorescence was measured on a FACScan
(BectoneDickinson, Rutherford, NJ, USA) ﬂow cytometer.
2.5. 20S proteasome activity assay in cell lysates
20S proteasome activity was measured using Suc-Leu-Leu-Val-
Tyr-7-amino-4-methylcoumarin (Enzo Life Sciences, Exeter, UK), a
ﬂuorogenic proteasome substrate, as described previously (15).
2.6. Measurement of ARE-dependent transcriptional activity
PC12 cells were stably transfected with an ARE-luciferase
construct and designated ARE reporter PC12 cells as described
previously (26). In the reporter gene assays, ﬁreﬂy luciferase ac-
tivity was measured in cell lysates using a luminometer by the
ONE-Glo™ Luciferase Assay System (Promega).
2.7. Small interfering RNA (siRNA) sequences and transfection
Stealth™ RNAi siRNAs were purchased from Life Technologies.
The siRNA sequence targeting Nrf2 was 50-UUUACACAGGGACGAU-
CACAGCCC-30 and that targeting Hemeoxygenase-1 (Ho-1) was 50-
AUGGCAUAAAUUCCCACUGCCACGG-30. Stealth™ RNAi Negative
Control Medium GC Duplex #2 (Life Technologies) was used as the
negative-control siRNA. PC12 cellswere transfectedwith each siRNA
using Lipofectamine 2000 according to themanufacturer's protocol.
Themediumwas changed at 9 h after transfection and cultureswere
treated with drugs from 24 h after transfection.
2.8. Real-time PCR analysis
Total RNA was extracted and reverse transcribed. Real-time PCR
was performed using SYBR® Premix Ex Taq™ II (Takara Bio). The
following primer sequences were used: Nrf2 forward, 50-GAGACGGC-
CATGACTGAT-30; Nrf2 reverse, 50-GTGAGGGGATCGATGAGTAA-30, g-
Glutamylcysteine synthetase (g-Gcs) forward, 50-CCTTCTGGCA-
CAGCACGTTG-30; g-Gcs reverse, 50-TAAGACGGCATCTCGCTCCT-30;
Ho-1 forward, 50-TGCTCGCATGAACACTCTG-30; Ho-1 reverse, 50-
TCCTCTGTCAGCAGTGCC-30; Glyceraldehyde 3-phosphate dehydroge-
nase (Gapdh) forward, 50-AGTGTAGCCCAGGATGCCCTT-30; and Gapdh
reverse, 50-GCCAAGGTCATCCATGACAAC-30. The mRNA levels of the
tested genes were quantiﬁed using standard curves generated by
serially diluted reference samples. The relative levels of target mRNAs
were analyzed by normalizing to GAPDHmRNA expression level.
2.9. Western blotting
Western blot analysis using cell lysates was performed as
described previously (24). Brieﬂy, whole-cell lysates were sepa-
rated on an SDSepolyacrylamide gel, followed by transfer to a
polyvinylidene ﬂuoride membrane (Millipore). The membranes
were probed with primary antibodies [anti-Nrf2 (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), anti-HO-1 (Stressgen, Victoria,
Canada), anti-b-actin (Sigma), and anti-GAPDH (Ambion, Austin,
TX, USA)] and a horseradish peroxidase-conjugated secondary
antibody (GE Healthcare, Little Chalfont, UK) for 1 h. The
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membrane-bound secondary antibody was detected using an
enhanced chemiluminescence detection system (GE Healthcare).
The band intensities were analyzed using the ImageJ 1.33u software
(National Institute for Health, Bethesda, MD, USA).
2.10. Measurement of intracellular reduced glutathione (GSH) levels
The levels of GSH were determined using monochlorobimane
(Sigma), which forms a ﬂuorescent conjugate with GSH, as
described previously (26).
2.11. Measurement of catalase activity
Catalase activity was determined on the basis of the peroxidatic
activity of catalase with methanol in the presence of hydrogen
peroxide as described previously (27). The formaldehyde produced
wasmeasured spectrophotometrically using 4-amino-3-hydrazino-
5-mercapto-1,2,4-triazole (Purpald) as a chromogen.
2.12. Statistics
The statistical signiﬁcance of the difference between three or
more groups of individual datawas analyzed by one-way analysis of
variance and post-hoc multiple comparisons using Turkey's test.
Statistical signiﬁcance was deﬁned as p < 0.05. Data are expressed
as mean ± SEM.
3. Results
3.1. Inhibitory effect of paraquat on 26S proteasome activity
PC12 cells transfected with pZsProSensor-1 (PC12 proteasome
sensor cells) were used for quantitating cellular ubiquitin-
dependent 26S proteasome activity. Treatment with paraquat
(50 mM) for 24 h caused an increase in ZsGreen ﬂuorescence, which
reﬂected the reduced activity of the 26S proteasome (Fig. 1A). A
ﬂow cytometric analysis also showed that paraquat increased
ZsGreen ﬂuorescence in the transfected cells (Fig. 1B). The marker
M1 was used to designate cells with low 26S-proteasome activity.
The increases in both the proportion of cells with a low 26S-pro-
teasome activity and the mean ﬂuorescence intensity of ZsGreen
reached a plateau 24 h after exposure to paraquat (Fig. 1C and D).
The extent of inhibition of the 26S proteasome by paraquat (50 mM)
corresponded to that afforded byMG132, a proteasome inhibitor, at
a concentration between 100 and 150 nM (Fig. 1E). PC12 cells
differentiated by NGF possess many important neurochemical
and signal transduction processes similar to dopaminergic neurons.
In NGF-differentiated PC12 cells, paraquat (50 mM) also time-
dependently increased ZsGreen ﬂuorescence (Fig. 1F). To examine
whether reactive oxygen species or endogenous dopamine partic-
ipates in paraquat-mediated 26S proteasomal inhibition, ascorbic
acid or a-methyl-p-tyrosine, which is an inhibitor of tyrosine hy-
droxylase, was applied from 24 h before and simultaneously with
paraquat. Ascorbic acid (1e10 mM) attenuated the paraquat-
induced inhibition of 26S proteasome activity in a concentration-
dependent manner (Fig. 1F). On the other hand, a-methyl-p-tyro-
sine (1mM) slightly increased the basal and paraquat-induced level
in 26S proteasome activity (Fig. 1G).
3.2. Inhibitory effect of paraquat on 20S proteasome activity
The 20S proteasome is the proteolytic core particle of the 26S
proteasome. The inhibitory effect of paraquat on 26S proteasome
activity may be attributed to dysfunction of 20S proteasome pro-
teolytic core activity. However, the effect of paraquat on 20S pro-
teasome activity in cell lysates was limited. Paraquat (50 mM)
slightly decreased 20S proteasome activity 48 h after exposure to
the drug (Fig. 2A). In contrast, MG132 (30e300 nM) markedly
suppressed 20S proteasome activity in a concentration-dependent
manner (Fig. 2B).
3.3. Inﬂuence of proteasome inhibition on the Nrf2eARE pathway
In agreement with previous reports (13e15), treatment with
MG132 (30e150 nM) or lactacystin (0.1e1 mM), which is another
proteasome inhibitor, for 9 h increased the level of the Nrf2 protein
(Fig. 3A and B). As a result, both MG132 and lactacystin increased
ARE-dependent transcriptional activity in a time-dependentmanner
(Fig. 3C and D). In addition, the effects of proteasome inhibitors on
paraquat-inducedcytotoxicitywere examined. Paraquat cytotoxicity
was signiﬁcantly attenuated by pre- and co-treatment with MG132
(30e100 nM) or lactacystin (0.3e1 mM; Supplementary Fig. S1).
Treatment with MG132 (not less than 150 nM) for 72 h caused
marked toxicity in PC12 cells (data not shown).
3.4. Activation of ARE-dependent transcription by paraquat
Next, we examined whether paraquat affected the Nrf2eARE
pathway. The amount of intracellular Nrf2 protein increased after
treatment with paraquat (50 mM) in a time-dependent manner
(Fig. 4A). However, no signiﬁcant changes were found in the
amount of Nrf2 mRNA, although Nrf2 mRNA tended to decrease
just after exposure to paraquat (Fig. 4B). In response to the upre-
gulation of the Nrf2 protein, treatment with paraquat (50 mM)
increased ARE-luciferase activity (Fig. 4C). In NGF-differentiated
PC12 cells, treatment with paraquat (50 mM) caused a rapid and
transient increase in ARE-luciferase activity (Fig. 4D). To conﬁrm
the involvement of Nrf2 in paraquat-induced ARE activation, ARE
reporter PC12 cells were transfected with an siRNA against Nrf2. In
our previous reports (26), mRNA level of Nrf2 was decreased to 50%
by the siRNA. Transfection of the siRNA suppressed the basal level
and the paraquat-induced increase in ARE-luciferase activity
(Fig. 4E). To examine whether the paraquat-induced ARE activation
affected cytotoxicity, cell viability was measured in Nrf2-
knockdown cells. For unknown reasons, PC12 cells acquired resis-
tance to paraquat toxicity after exposure to Lipofectamine 2000
(Supplementary Fig. S2). Therefore, paraquat was used at a con-
centration of 250 mM to induce sufﬁcient toxicity in siRNA-
transfected PC12 cells. PC12 cells transfected with the Nrf2 siRNA
Fig. 1. Paraquat decreases 26S proteasome activity in living cells. (A, B) Effect of paraquat on 26S proteasome activity in ﬂuorescence images (A) and ﬂow cytometry (B). PC12
proteasome sensor cells were treated with paraquat (50 mM) for 24 h. Scale bar, 50 mm. A marker (M1) is placed to indicate the percentage of cells with low proteasome activity
(<3%) under normal conditions. (C, D) Temporal change in 26S proteasome activity in response to paraquat. PC12 proteasome sensor cells were treated with paraquat (50 mM) for
the indicated periods. C: Percentage of cells in gate M1. D: Fluorescence intensity per cell. ZsGreen ﬂuorescence was determined by ﬂow cytometry. (n ¼ 3) E: Effect of MG132 on
26S proteasome activity. PC12 proteasome sensor cells were treated with MG132 (100e200 nM) or paraquat (50 mM) for 24 h. (n ¼ 3) F: Effect of paraquat on 26S proteasome
activity in NGF-differentiated PC12 cells. PC12 proteasome sensor cells were differentiated by NGF (10 ng/mL) for 4 days. Treatment with paraquat (50 mM) for 3e48 h was
conducted as differentiation period was equalized. (n ¼ 3e4) (GeH) Effects of ascorbic acid and a-methyl-p-tyrosine on paraquat-induced inhibition of 26S proteasome activity.
PC12 proteasome sensor cells were pretreated with 1e10 mM ascorbic acid (G) or 0.1e1 mM a-methyl-p-tyrosine (H) for 24 h, and exposed to 50 mM paraquat in the presence of
ascorbic acid or a-methyl-p-tyrosine for 24 h. (n ¼ 4) *p < 0.05, **p < 0.01, ***p < 0.001 compared with the control. #p < 0.05, ###p < 0.001 compared with paraquat alone.
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were more vulnerable to paraquat toxicity (250 mM) than those
transfected with the control siRNA (Fig. 4F).
3.5. Involvement of the induction of g-GCS in paraquat toxicity
The Nrf2eARE pathway is critical in mediating the induction of
antioxidant enzymes, such as g-GCS, a rate-limiting enzyme in
glutathione synthesis, catalase, and HO-1. Treatment with paraquat
(50 mM) increased the g-GCSmRNA level and GSH content in a time-
dependent manner (Fig. 5A and B). To inhibit the increase in the GSH
content by paraquat, BSO (1 mM), an inhibitor of g-GCS, was co-
applied with paraquat, suppressing the basal level and the paraquat-
induced increase in the GSH content (Fig. 5C). Co-administration of
BSO (0.03e1 mM) exacerbated paraquat-induced cytotoxicity,
although BSO (1 mM) alone had no effect on cell viability (Fig. 5D).
3.6. Involvement of the induction of catalase in paraquat toxicity
Treatment with paraquat (50 mM) also increased the catalase
mRNA level and activity (Fig. 6A and B). To suppress this increase in
catalase activity by paraquat, 3-amino-1,2,4-triazole, an inhibitor of
catalase, was co-applied with paraquat. Co-administration of 3-
amino-1,2,4-triazole (1e30 mM) exacerbated the paraquat-
induced cytotoxicity, although 3-amino-1,2,4-triazole (30 mM)
alone had no effect on cell viability (Fig. 6C).
3.7. Noninvolvement of the induction of HO-1 in paraquat toxicity
Treatment with paraquat (50 mM) also increased HO-1 mRNA
and protein levels (Fig. 7A and B). The mRNA and protein levels
peaked at around 24 h, gradually decreasing. To eliminate the
Fig. 2. Paraquat has only a limited inﬂuence on 20S proteasome activity in cell lysates. A: Effect of paraquat on 20S proteasome activity. PC12 cells were treated with paraquat
(50 mM) for the indicated periods. B: Effect of MG132 on 20S proteasome activity. PC12 cells were treated with MG132 (30e300 nM) for 24 h. (n ¼ 3) **p < 0.01, ***p < 0.001
compared with the control.
Fig. 3. Proteasome inhibitors activate the Nrf2eARE pathway. (A, B) Effects of proteasome inhibitors on Nrf2 protein levels. PC12 cells were treated with MG132 (30e300 nM; A) or
lactacystin (0.1e1 mM; B) for 9 h. (C, D) Effects of proteasome inhibitors on ARE-dependent transcriptional activity. ARE reporter PC12 cells were treated with 150 nM MG132 (C) or
1 mM lactacystin (D) for 3e12 h. (n ¼ 3) *p < 0.05, ***p < 0.001 compared with the control.
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contribution of the upregulation of HO-1 protein by paraquat, PC12
cells were transfected with an siRNA against HO-1. Transfection of
this siRNA suppressed the basal level and the paraquat-induced
increase in HO-1 protein levels (Fig. 7C). However, PC12 cells
transfected with the HO-1 siRNA exhibited a similar cytotoxicity to
paraquat (250 mM) as did the control siRNA (Fig. 7D). Furthermore,
although bilirubin, one of end products of hememetabolism byHO-
1, possesses radical scavenging activity (28), co-administration of
bilirubin (3e10 mM) failed to inhibit paraquat-induced cytotoxicity
(Fig. 7E).
Fig. 4. Paraquat activates the Nrf2eARE pathway. (A, B) Effect of paraquat on Nrf2 protein (A) and mRNA (B) levels. PC12 cells were treated with paraquat (50 mM) for 3e24 h. The
levels of Nrf2 were normalized to those of GAPDH. (n ¼ 4) C: Effect of paraquat on ARE-dependent transcriptional activity. ARE reporter PC12 cells were treated with paraquat
(50 mM) for 1e48 h. (n ¼ 3) D: Effect of paraquat on ARE-dependent transcriptional activity in NGF-differentiated PC12 cells. ARE reporter PC12 cells were differentiated by NGF
(10 ng/mL) for 4 days. Treatment with paraquat (50 mM) for 1e48 h was conducted as differentiation period was equalized. (n ¼ 3) E: Effect of an Nrf2 siRNA on paraquat-induced
ARE activation. ARE reporter PC12 cells were transfected with an Nrf2 siRNA before treatment with paraquat (50 mM) for 24 h. (n ¼ 3) F: Effect of an Nrf2 siRNA on paraquat toxicity.
PC12 cells were transfected with an Nrf2 siRNA before treatment with paraquat (250 mM) for 48 h. (n ¼ 4) *p < 0.05, ***p < 0.001 compared with the control. yyyp < 0.001. n.s., not
signiﬁcant.
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4. Discussion
Genetic information acquired from familial PD cases implicates
defective UPS in PD pathogenesis. However, because more than 90%
PDcases are sporadic, the elucidation ofUPS function during the cell-
death process induced by environmental dopaminergic neurotoxins
is important for understanding the etiology of this disease. In the
present study,wedemonstrated that paraquat excerted an inhibitory
effect on 26S proteasome activity in living cells without a decline in
20S proteasome activity. Furthermore, we propose a role of 26S
proteasomeactivity in theNrf2eAREpathwayactivationbyparaquat.
Our data showed that paraquat inhibited 26S proteasome ac-
tivity, although the precise mechanisms remain to be clariﬁed.
However, several issues were noted in this study. First, the inhibi-
tion of the 26S proteasome by paraquat was unlikely to be a
consequence of a cell-death process, because the decrease in 26S
proteasome activity occurred before cell death began. 26S Protea-
some activity decreased from 6 h after exposure to paraquat
(50 mM) in the present study, whereas cell viability reduced from
36 h onward in our previous report (24). Second, the elevation of
reactive oxygen species by paraquat appears to be involved in the
inhibitory effect on 26S proteasome activity. Because ascorbic acid
efﬁciently scavenges the superoxide anion (29), the superoxide
anion produced via a redox cycling mechanism of paraquat may
trigger the inhibition of 26S proteasome activity. In addition,
dopamine oxidation products exert strong inhibitory effects on 20S
proteasome activity (30). However, the restorative effect of
a-methyl-p-tyrosine on the inhibitory effect of paraquat on 26S
proteasome activity was limited, suggesting the elevation of
dopamine by paraquat does not directly cause the inhibition of 26S
proteasome activity. Third, the inhibitory effect of paraquat on 26S
proteasome activity is unlikely to be mediated by direct interaction
with the 20S proteasome, because treatment with paraquat yielded
no obvious inhibition of 20S proteasome activity in cell lysates.
Reinheckel et al. (31) demonstrated that the 26S proteasome is
more vulnerable to oxidative stress compared with the 20S pro-
teasome. In fact, paraquat has been reported to decrease protein
levels of 19S proteasome subunits, but not 20S proteasome alpha or
beta subunits (32). However, in DJ-1-deﬁcient mice, paraquat has
been reported to decrease protein levels of both 19S and 20S pro-
teasome subunits (33). Another study proposes that a decrease in
proteasomal proteolytic activity by paraquat is not due to loss of the
19S or 20S components (34). Furthermore, oxidative stress could
upregulate 20S proteasome subunits via the Nrf2eARE pathway
(35). Although an association between paraquat and proteasome is
complicated and differs by experimental conditions, time-course
study is necessary to better understand the role of proteasome
activity in paraquat toxicity.
Proteasome inhibition is hypothesized to play an important
role in mediating cellular toxicity in PD. Severe inhibition of
proteasome activity induces dopaminergic neuronal death
in vitro and in vivo (11, 12). Conversely, previous data from our
and other groups demonstrated that mild inhibition of protea-
some activity provided dopaminergic neuroprotection in vitro
Fig. 5. Induction of g-GCS participates in alleviation of paraquat toxicity. (A, B) Temporal changes in g-GCS mRNA expression (A, n ¼ 6) and intracellular GSH content (B, n ¼ 3) in
response to paraquat. PC12 cells were treated with 50 mM paraquat for 6e48 h. C: Effect of BSO on intracellular GSH content, which was upregulated by paraquat. PC12 cells were
treated with 50 mM paraquat for 24 h in the presence or absence of BSO (1 mM). (n ¼ 4) D: Effect of BSO on paraquat toxicity. PC12 cells were treated with 50 mM paraquat for 24 h in
the presence or absence of BSO (0.03e1 mM). (n ¼ 4) **p < 0.01, ***p < 0.001 compared with the control. ##p < 0.01, ###p < 0.001 compared with paraquat alone.
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and in vivo (16e18). They propose the activation of the Nrf2eARE
pathway as a probable mechanism underlying the protective
effect of proteasome inhibitors (15, 18). Recently, it has been
reported that knock-out of 19S proteasome regulatory subunit
leads to activation of the Nrf2eARE pathway (36). Therefore,
these reports raise the possibility that a mild reduction of 26S
proteasome activity during paraquat toxicity can serve as a
cellular defense mechanism to protect against oxidative stress. At
least in experimental models of PD, there is still a dispute over
whether dysfunction of proteasome activity is responsible for
cellular toxicity. Similarly, in NGF-differentiated PC12 cells,
paraquat induced a decrease in 26S proteasome activity and the
activation of the Nrf2eARE pathway. Because NGF increase the
expression level of the dopamine transporter in PC12 cells (37),
cellular sensitivity to paraquat was likely to differ from naive
cells. Further study is required to elucidate the temporal
response to paraquat in NGF-differentiated PC12 cells.
Our ﬁndings demonstrated that paraquat upregulated intra-
cellular Nrf2 protein level and activated the Nrf2eARE pathway.
Because Nrf2 is an ubiquitineproteasome substrate (13), the
inhibitory effect of paraquat on 26S proteasome activity can
induce the accumulation of Nrf2. Another possibility is that acti-
vation of the Nrf2eARE pathway by paraquat may upregulate Nrf2
protein level. However, there is a dispute over whether activation
of the Nrf2eARE pathway increases Nrf2 mRNA level (14, 38).
Furthermore, we showed that paraquat did not increase Nrf2
mRNA levels. Thus, the Nrf2 protein level increased by paraquat
seems to be the result from a post-transcriptional mechanism,
rather than of an increase in Nrf2 transcription. Rather, Nrf2
mRNA levels tended to be transiently decreased by paraquat
(Fig. 4B). Several studies have shown that microRNA-34a, one of
non-coding RNA species, negatively regulates the mRNA levels of
Nrf2 (39, 40). In fact, exposure to paraquat is reported to increase
the expression levels of microRNA-34a (41). Nevertheless, the fact
that paraquat increased Nrf2 protein levels suggested that the
inhibition of degradation of Nrf2 protein predominates over the
suppression of translation of Nrf2 mRNA.
More importantly, suppression of the activation of the
Nrf2eARE pathway by RNA interference potentiated paraquat
toxicity. This experimental result indicates that the activation of the
Nrf2eARE pathway induced by paraquat plays a role in a cellular
defense mechanism to protect against paraquat toxicity. Among
phase 2 detoxifying and antioxidant enzymes which are upregu-
lated by the Nrf2eARE pathway, we showed paraquat increased the
expression of g-Gcs, Catalase, and Ho-1. Because inhibition of g-GCS
and catalase, or knockdown of HO-1 alone did not affect cell
viability, PC12 cells may be maintained at low levels of oxidative
stress under normal conditions. Our data indicate that the upre-
gulation of g-GCS and catalase contributes to the protective effect
afforded by the paraquat-induced activation of the Nrf2eARE
pathway, whereas the upregulation of HO-1 by paraquat may not
participate in its toxicity. Catalase and GSH seem to play a role to
suppress reactive oxygen species under oxidative conditions
induced by paraquat. Catalase efﬁciently eliminates hydrogen
peroxide, which can be generated by single-electron transfer of the
superoxide anion produced via a redox cycling mechanism of
Fig. 6. Induction of catalase participates in alleviation of paraquat toxicity. (A, B) Temporal changes in catalase mRNA expression (A, n ¼ 3) and activity (B, n ¼ 3e4) in response to
paraquat. PC12 cells were treated with 50 mM paraquat for 6e48 h. C: Effect of a catalase inhibitor on paraquat toxicity. PC12 cells were treated with 50 mM paraquat for 24 h in the
presence or absence of 3-amino-1,2,4-triazole (1e30 mM). (n ¼ 4) **p < 0.01, ***p < 0.001 compared with the control. #p < 0.05, ###p < 0.001 compared with paraquat alone.
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paraquat. GSH does not only remove cellular hydrogen peroxide as
a substrate for glutathione peroxidase but also reacts directly with
the superoxide anion (42). In contrast, although bilirubin is an
efﬁcient scavenger of hydroxyl radicals, the reaction of bilirubin
with the superoxide anion is rather slow (28). This can explain the
observation that suppression of HO-1 upregulation did not exac-
erbate paraquat toxicity. This ﬁnding may be relevant to our pre-
vious report, which showed that trolox (which scavenges the
superoxide anion less efﬁciently) only had a minor effect on para-
quat toxicity (24).
In summary, the present study suggests that compensatory
activation of the Nrf2eARE pathway via inhibition of 26S protea-
some serves as part of a cellular defense mechanism to protect
against paraquat toxicity. However, further experiments are
required to verify that the 26S proteasomal inhibition is associated
with the activation of the Nrf2eARE pathway. Although it is
uncertain whether the proteasomal dysfunction observed in PD is
directly linked to the Nrf2eARE pathway, the nuclear localization of
Nrf2 is observed in remaining dopaminergic neurons of PD patients
(6). Taken together, our ﬁndings may provide insights into the
relationship between proteasome activity and the Nrf2eARE
pathway in PD pathogenesis.
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Fig. 7. Induction of HO-1 does not affect paraquat toxicity. (A, B) Temporal changes in HO-1 mRNA (A, n ¼ 3e4) and protein (B, n ¼ 7) expression in response to paraquat. PC12 cells
were treated with 50 mM paraquat for 6e48 h. C: Effect of an HO-1 siRNA on the upregulation of HO-1 induced by paraquat. PC12 cells were transfected with an HO-1 siRNA before
treatment with paraquat (50 mM) for 24 h. D: Effect of an HO-1 siRNA on paraquat toxicity. PC12 cells were transfected with an HO-1 siRNA before treatment with paraquat (250 mM)
for 48 h. (n ¼ 4) E: Effect of bilirubin on paraquat toxicity. PC12 cells were treated with 50 mM paraquat for 24 h in the presence or absence of bilirubin (3e30 mM). (n ¼ 4)
*p < 0.05,**p < 0.01, ***p < 0.001 compared with the control. n.s., not signiﬁcant.
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Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.jphs.2015.09.003.
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